Investigating bone changes around a new 3D-printed hip implant
Official title: Bone Remodeling Around a 3D-printed Highly-porous Trabecular Titanium Acetabular Cup in Primary Total Hip Arthroplasty
Run by Permedica spa · NCT06287021 · Data updated 2026-11-12
This study is testing whether a new 3D-printed hip implant helps improve bone strength better than a standard hip implant in patients getting hip replacement surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 85 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Permedica spa Industry-sponsored |
| Locations | 2 sites (Milan and 1 other locations) |
| Status | Recruiting |
| Started | April 9, 2024 |
| Main results expected | June 2028 |
| Study ends | June 2028 |
| Registry record updated | September 2, 2025 |
| Trial ID | NCT06287021 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 40-85 undergoing unilateral cementless primary total hip arthroplasty due to primary or secondary hip osteoarthritis.
✕Probably not a fit
Patients with specific bone disorders or those outside the age criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare the changes in bone mineral density around a highly-porous 3D-printed titanium acetabular cup versus a standard hydroxyapatite/titanium plasma-sprayed cup in patients undergoing total hip arthroplasty. A total of 50 patients will be randomly assigned to receive either the investigational or control cup, with bone density measured using DEXA scans at various time points over a two-year follow-up period. The study seeks to determine if the new implant design offers superior osseointegration and stability compared to traditional methods.
Why it matters
Potential benefit: If successful, this study could lead to improved long-term outcomes and stability for patients receiving total hip arthroplasty.
How similar studies have gone: While the use of highly-porous tantalum components has shown success, this specific approach with 3D-printed titanium structures is relatively novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient candidated to undergo unilateral cementless primary total hip arthroplasty with Jump System Traser® cup or Jump System HAX-Pore® cup by Permedica Orthopaedics (study sponsor). * Patient with primary or secondary hip osteoarthritis; * Patient who has given informed consent; Exclusion Criteria: * Male patients younger than 40 years or older than 85 years; * Female patients younger than 50 years or older than 85 years; * Childbearing; * Patients not indicated for receiving the investigational devices; * Patients not indicated for receiving cementless metaphyseal short femoral stems by Permedica Orthopaedics as the "Exacta RS" or "Exacta S" brand; * Patients with rheumatoid arthritis, avascular osteonecrosis, severe hip dysplasia (grade III-IV according to Crowe classification), Perthes disease, Paget disease, femoral neck fracture, pelvic fracture or sequelae of previous surgical procedures or trauma to the ipsilateral hip; * Patients with bone disorders; * Patients with diabetes; * Patients under PTH (parathyroid hormone), corticosteroid, or osteoporosis pharmacological therapy; * Patients with disabling disease in the contralateral limb; * Patients with BMI \> 30 or \< 18; * Patients not willing to follow the study protocol; * Patients incapable to understand the study protocol; * Patients addicted to alcohol or drugs; * Patients already enrolled in other clinical investigations;
Where it's running
-
IRCCS Istituto Clinico San Siro
Milan, Italy Recruiting -
IRCCS Ospedale Galeazzi-Sant'Ambrogio
Milan, Italy Recruiting
Study contacts
- Principal investigator: Giuseppe Peretti, MD — IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milan, Italy
- Study coordinator: Lorenzo Banci, MSc
- Email: lorenzo.banci@permedica.it
- Phone: +390399514811
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Quadroiliac Plane Block vs Transmuscular Quadratus Lumborum Block for Hip Replacement Pain
This study tests whether the Quadroiliac Plane Block provides better postoperative pain relief and lower opioid use than the transmuscular quadratus lumborum block after total hip arthroplasty conducted under spinal anesthesia.
-
Deep iliacus plane block vs transmuscular quadratus lumborum block for hip surgery pain relief
This study tests whether the deep iliacus plane block provides better pain relief and recovery than the transmuscular quadratus lumborum block after total hip replacement.
-
Analgesia after total hip replacement using SA-QLB vs PENG block
This study tests whether the SA-QLB or the PENG block provides better pain relief for adults having a total hip replacement.
-
Quadro‑Iliac Plane Block versus Erector Spinae Plane for pain after total hip replacement
This will test whether the quadro‑iliac plane block or the erector spinae plane block controls pain better after total hip replacement in adults having spinal anesthesia.
-
Ultrasound-guided Quadro-Iliac Plane block for pain after total hip replacement
This trial will test whether an ultrasound-guided Quadro-Iliac Plane (QIP) block reduces opioid use and pain in adults having elective primary total hip arthroplasty.
-
Intraoperative methadone for pain control after total hip replacement
This trial tests whether a single intraoperative IV dose of methadone lowers immediate postoperative pain and reduces opioid use in adults having elective total hip replacement with spinal anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.